by Seth J. Baum MD Recently, there have been several articles discussing the development, efficacy, cost and long-term impact of novel cholesterol lowering drugs – called PCSK9 inhibitors – new drugs that show the capacity to greatly reduce the levels of LDL, or “bad”, cholesterol in an individual’s bloodstream. Insurance providers have pushed back aggressively…

Read More

by Seth J. Baum, MD It’s National Cholesterol Education Month and we have fittingly entered a new era in lipid management. We now know that elevated LDL cholesterol causes heart attacks and strokes. Studies of all types have proved this. The most persuasive proof comes from genetics, specifically Mendelian Randomization studies. Recently our increased genetic…

Read More

by Seth J. Baum, MD I’ve been speaking and writing about; and basically “living” the ASPC annual meeting for many months. Now it has come and gone. And it was spectacular! A few hundred attendees representing diverse medical, nursing, pharmaceutical, and basic science disciplines enjoyed clinically relevant lectures delivered by many of America’s most influential…

Read More